AMGN vs METCI
Amgen Inc (AMGN) versus Ramaco Resources, Inc. 8.250% Senior Notes due 2030 (METCI) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Ramaco Resources, Inc. 8.250% Senior Notes due 2030 (METCI) common stock listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
METCI does not have a complete income-statement cache yet.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. METCI currently screens at market cap $0.
Not investment advice. Open the AMGN and METCI stock pages for the full models.
Not investment advice.